An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. | MicrobiomeTrials

← Back to trials

NCT05939414

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-03-12Est. Completion: 2028-04-25

Enrollment target: 450 participants

Locations

Highlands Oncology Group, Fayetteville, Arkansas, United States
VA Greater LA Healthcare System, Los Angeles, California, United States
VA Palo Alto Health Care System, Palo Alto, California, United States
Stanford University, Palo Alto, California, United States
UCSF, San Francisco, California, United States
Rocky Mountain Cancer Centers, Denver, Colorado, United States
Cancer Specialists of North Florida, Jacksonville, Florida, United States
Woodlands Medical Specialists, Pensacola, Florida, United States
Piedmont Healthcare, Atlanta, Georgia, United States
University of Chicago, Chicago, Illinois, United States
The Cancer Institute of Alexian Brothers, Elk Grove, Illinois, United States
Unity Point Clinic, Des Moines, Iowa, United States
University of Kansas Hospital, Kansas City, Kansas, United States
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States
East Jefferson Hospital, Metairie, Louisiana, United States
University of Maryland Medical Ctr, Baltimore, Maryland, United States

Other microbiome trials you might be interested in

HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)Recruiting

Prostate Cancer Metastatic DiseaseOligometastatic Prostate Cancer (OMPC)

The investigators propose redefining this concept by focusing on volume rather than the number of metastases. To achieve…

Saint-Herblain, FranceEst. completion May 1, 2028

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)WITHDRAWN

Oligometastatic Prostate Cancer (OMPC)Prostate Cancer (Adenocarcinoma)Ablation Techniques

The TA-P-OLIM Study (Percutaneous Thermo-Ablation of Prostate Cancer OligoMetastasis) is a prospective, interventional p…

Ghent, BelgiumCompleted Apr 1, 2031

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.